Acadia Pharmaceuticals | ACAD - 贷款资金

金融业

USD

USD 1.61B

现金及等价物

USD 851.46M

USD 24.79M

USD 1.1B

USD 305.52M

USD 52.19M

USD -4.62M

USD 20.32M

653

EPS每股收益

USD 0.02

股本和储备

USD 1.25B

USD 243.27M

债务利息支出

USD 0

USD 8.33M

USD 0

USD 4.1B

USD 3.64M

USD 272.68M

USD -4.62M

普通股股本

USD 169.18M

10.08

USD 3.98M

USD 268.06M

销售和管理费用

USD 160.79M

USD 31.57M

贸易债权人

USD 12.25M

应收帐款人

USD 148.38M

	贷款资金	更改		日
Acadia Pharmaceuticals	USD 0		0	2025-03
ALKERMES	USD 1.48B		1.2B	2026-03
Alnylam Pharmaceuticals	USD 2.48B		931K	2026-03
Biogen	USD 6.29B		1.7M	2026-03
BioMarin Pharmaceutical	USD 1.43B		833.11M	2026-03
Bristol-Myers Squibb	USD 42.15B		698M	2026-03
Cara Therapeutics	USD 0		0	2025-03
Cytokinetics	USD 247.21M		868.77M	2026-03
Eisai	JPY 134.78B		12M	2026-03
Eli Lilly	USD 39.37B		1.5B	2026-03
Incyte	USD 29.41M		785K	2026-03
J&J	USD 37.53B		1.91B	2026-03
Moderna	USD 603M		7M	2026-03
Neurocrine Biosciences	USD 169.5M		500K	2023-03
Pfizer	USD 60.57B		1.08B	2026-03
Prothena	USD 0		0	2024-12
PTC Therapeutics	USD 286.94M		1.74B	2026-03
Sarepta Therapeutics	USD 838.16M		9.19M	2026-03
Ultragenyx Pharmaceutical	USD 1.13B		19M	2026-03
Vanda Pharmaceuticals	USD 3.15M		3.15M	2024-12
Vertex Pharmaceuticals	USD 106.7M		4.7M	2025-12